Φορτώνει......
Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy
A significant proportion of patients infected with SARS‐CoV‐2 develop severe respiratory symptoms due to an excessive immune response. Treatment of this condition may include immunosuppressive therapies, such as IL‐6 receptor antagonists and corticosteroids, which pose a risk for patients with activ...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Viral Hepat |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537127/ https://ncbi.nlm.nih.gov/pubmed/32969557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvh.13410 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|